United Therapeutics CEO Martine Rothblatt reports $5.54 million common share disposal
UTHR•United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on October 22, 2026, and exercised 9,500 stock options at $117.76 per share. The family trusts involved held 324,443 common shares after the transactions, unchanged from before.
1. Share transactions
Rothblatt sold 9,500 common shares and exercised 9,500 stock options at $117.76 per share on October 22, 2026. The family trusts involved held 324,443 common shares after the transactions, unchanged from before.
